Evaluation of the expression of bone marrow-derived mesenchymal stem cells and cancer-associated fibroblasts in the stroma of gastric cancer tissue.

BM‐MSC CAF gastric cancer immunohistochemistry

Journal

Annals of gastroenterological surgery
ISSN: 2475-0328
Titre abrégé: Ann Gastroenterol Surg
Pays: Japan
ID NLM: 101718062

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 27 12 2019
revised: 03 04 2020
accepted: 17 04 2020
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 30 7 2020
Statut: epublish

Résumé

Cancer-associated fibroblasts (CAFs) generated by bone marrow-derived mesenchymal stem cells (BM-MSCs) play an important role in cancer progression. In this study, we investigated the relationships of BM-MSCs and CAFs in resected gastric cancers with the clinicopathological factors of patients. We analyzed 120 gastric cancer patients who underwent gastrectomy. Immunostaining was performed with an anti-CD271 antibody (BM-MSCs) and anti-α-smooth muscle actin (αSMA) antibody (CAFs). Staining intensity was used to divide patients into low and high expression groups. Observation sites in cancer tissues were invasive, central, and whole portions. Expression of αSMA was significantly related to depth of tumor invasion (T), lymph node metastasis (N), lymphatic invasion (ly), venous invasion (v), and stage. Expression of CD271 was significantly related to v, stage, stromal volume, and tumor infiltration pattern (INF). Overall survival (OS) of the high expression group was significantly lower than that of the low expression group for both αSMA and CD271. Multivariate analysis showed that N, αSMA (whole), and CD271 (invasive) were independent prognostic factors. Cancer-associated fibroblasts and BM-MSCs are related to the progression, invasion, and prognosis of gastric cancer and may be therapeutic targets of gastric cancer.

Identifiants

pubmed: 32724891
doi: 10.1002/ags3.12347
pii: AGS312347
pmc: PMC7382433
doi:

Types de publication

Journal Article

Langues

eng

Pagination

464-474

Informations de copyright

© 2020 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology Surgery.

Déclaration de conflit d'intérêts

Funding: This study was not funded. Conflicts of interest: The authors declare no conflicts of interests for this article. Author Contribution: The conception or design of the work, or acquisition, analysis or interpretation of data for the work: Taizan Minami, Keishiro Aoyagi, Taro Isobe, Yuya Tanaka, Hideaki Kaku. Drafting the work or revising it critically for important intellectual content: Taizan Minami, Keishiro Aoyagi. Analysis of histological findings or performing immunohistochemical staining: Taizan Minami, Keishiro Aoyagi, Akihiko Kawahara. Final approval of the version to be published; Keishiro Aoyagi, Naotaka Murakami, Fumihiko Fujita, Yoshito Akagi. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work: Yoshito Akagi.

Références

Drug Des Devel Ther. 2014 Dec 09;8:2449-62
pubmed: 25525335
PLoS One. 2014 Sep 15;9(9):e106976
pubmed: 25222747
Cancer Lett. 2009 Feb 8;274(1):61-71
pubmed: 18849111
Cancer Res. 2010 Sep 1;70(17):6945-56
pubmed: 20699369
Mol Biol Cell. 2007 Sep;18(9):3533-44
pubmed: 17615296
Gastric Cancer. 2013 Apr;16(2):155-66
pubmed: 22850801
J Biochem. 2012 Jun;151(6):563-71
pubmed: 22528665
Gastric Cancer. 2011 Jun;14(2):101-12
pubmed: 21573743
PLoS One. 2012;7(12):e52682
pubmed: 23300742
Exp Hematol. 2002 Jul;30(7):783-91
pubmed: 12135677
Oncogene. 2012 Jun 28;31(26):3190-201
pubmed: 22037216
Tissue Eng. 2005 Jul-Aug;11(7-8):1198-211
pubmed: 16144456
Cancer Res. 2008 Feb 1;68(3):918-26
pubmed: 18245495
Science. 1997 Apr 4;276(5309):71-4
pubmed: 9082988
Haematologica. 2009 Feb;94(2):173-84
pubmed: 19066333
Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):380-4
pubmed: 21081113
Nature. 2007 Oct 4;449(7162):557-63
pubmed: 17914389
Nat Rev Cancer. 2007 Feb;7(2):139-47
pubmed: 17218951
Cancer Sci. 2013 Feb;104(2):157-64
pubmed: 23121112
Exp Cell Res. 1988 Feb;174(2):533-9
pubmed: 2828087
PLoS One. 2012;7(9):e45272
pubmed: 23028899
J Cell Mol Med. 2012 Aug;16(8):1827-39
pubmed: 21973026
Cancer Cell. 2011 Feb 15;19(2):257-72
pubmed: 21316604
Science. 2009 Jun 26;324(5935):1666-9
pubmed: 19556498
EMBO J. 2011 Feb 16;30(4):783-95
pubmed: 21224849
Oncol Lett. 2015 Mar;9(3):1221-1226
pubmed: 25663886
J Cell Biol. 1982 Oct;95(1):333-9
pubmed: 7142291

Auteurs

Taizan Minami (T)

Department of Surgery Kurume University School of Medicine Fukuoka Japan.

Keishiro Aoyagi (K)

Department of Surgery Kurume University School of Medicine Fukuoka Japan.

Akihiko Kawahara (A)

Department of Diagnostic Pathology Kurume University School of Medicine Fukuoka Japan.

Naotaka Murakami (N)

Department of Surgery Kurume University School of Medicine Fukuoka Japan.

Taro Isobe (T)

Department of Surgery Kurume University School of Medicine Fukuoka Japan.

Yuya Tanaka (Y)

Department of Surgery Kurume University School of Medicine Fukuoka Japan.

Hideaki Kaku (H)

Department of Surgery Kurume University School of Medicine Fukuoka Japan.

Fumihiko Fujita (F)

Department of Surgery Kurume University School of Medicine Fukuoka Japan.

Yoshito Akagi (Y)

Department of Surgery Kurume University School of Medicine Fukuoka Japan.

Classifications MeSH